-+ 0.00%
-+ 0.00%
-+ 0.00%

SITRYX REPORTS POSITIVE PHASE 1B RESULTS FOR FIRST-IN-CLASS ORAL PKM2 MODULATOR SYX-5219 IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS

Reuters·10/13/2026 11:06:17

Please log in to view news